Ganesh Venkataraman

2009

In 2009, Ganesh Venkataraman earned a total compensation of $649.7K as Chief Scientific Officer and Senior Vice President, Research at Momenta Pharmaceuticals, a 4% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$77,328
Option Awards$151,707
Salary$314,668
Stock Awards$94,131
Other$11,847
Total$649,681

Venkataraman received $314.7K in salary, accounting for 48% of the total pay in 2009.

Venkataraman also received $77.3K in non-equity incentive plan, $151.7K in option awards, $94.1K in stock awards and $11.8K in other compensation.

Rankings

In 2009, Ganesh Venkataraman's compensation ranked 5,944th out of 9,885 executives tracked by ExecPay. In other words, Venkataraman earned more than 39.9% of executives.

ClassificationRankingPercentile
All
5,944
out of 9,885
40th
Division
Manufacturing
2,148
out of 3,690
42nd
Major group
Chemicals And Allied Products
461
out of 871
47th
Industry group
Drugs
306
out of 643
52nd
Industry
Biological Products, Except Diagnostic Substances
58
out of 138
58th
Source: SEC filing on April 26, 2011.

Venkataraman's colleagues

We found six more compensation records of executives who worked with Ganesh Venkataraman at Momenta Pharmaceuticals in 2009.

2009

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2009

Steven Brugger

Momenta Pharmaceuticals

Chief Operating Officer

2009

James Roach

Momenta Pharmaceuticals

Chief Medical Officer

2009

John Bishop

Momenta Pharmaceuticals

Senior Vice President, Pharmaceutical Sciences

2009

Ganesh Kaundinya

Momenta Pharmaceuticals

Chief Scientific Officer

2009

Richard Shea

Momenta Pharmaceuticals

Chief Financial Officer

You may also like